Innovations in Stretchable Biosensors, Implantable Neurostimulators, Needle-free Vaccine Delivery, and Nanomaterials

Share this:
Published: 16 Mar 2018

The latest edition of Medical Device TOE covers stretchable biosensors, implantable neurostimulators, needle-free vaccine delivery, and nanomaterials. Innovations profiled include a stretchable body-worn sensor for skin health monitoring, a microwave system for treating pre-cancerous cells caused by HPV, a spinal cord stimulator for dual therapies, a fully synthetic transcatheter valve for congenital heart diseases, a needle-free vaccine delivery technology, and a fully-integrated bioabsorbable vascular closure system. The Medical Device TechVision Opportunity Engine (TOE) analyzes and reports on new and emerging technologies and advances in R&D; product development; and regulatory matters related to neurology, ophthalmology, respiratory/anesthesia, wound care and management, surgical tools and instrumentation, drug delivery, orthopedics, endoscopy, cardiology, and monitoring. Medical devices and imaging technology and innovation research covers cutting-edge global developments in medical devices and imaging sectors such as biosensors, biomaterials, biomechanics, microtechnologies, nanotechnologies, assistive technologies, and imaging technologies and platforms. Keywords: Nanomaterials, breath analyser, VOC biomarkers, implantable neurostimulators, needle-free vaccine delivery, transcatheter


Features of this research


Help Desk

Full list of offices

For more information and general enquiries, contact Frost & Sullivan near you.

North America
tel: +1.877.463.7678

Select a location near you..